Vishnu Chemicals Limited
Outcome of Board Meeting
Vishnu Chemicals Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with a net profit of ₹3,964.22 lakhs and earnings per share of ₹5.89.
BSE & NSE corporate filings with AI summaries
Vishnu Chemicals Limited
Vishnu Chemicals Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with a net profit of ₹3,964.22 lakhs and earnings per share of ₹5.89.
Sportking India Ltd
Sportking India Ltd has announced unaudited financial results for the quarter ended 30th June 2026, with revenue from operations at Rs. 763677.64 lakhs and profit before tax at Rs. 4398.22 lakhs. The company has also announced a change in the designation of Non-Executive Director, Mrs. Anjali Avasthi, to Executive Director, subject to shareholder approval.
Saptak Chem And Business Ltd
Saptak Chem And Business Ltd announced its quarterly results for June 2026, with a net loss of Rs. 4.85 lakhs. The company's revenue from operations was zero, while other income was also zero. Expenses were Rs. 4.85 lakhs, with employee benefits expense being Rs. 0.80 lakhs and other expenses being Rs. 4.05 lakhs. The company's net loss for the quarter was Rs. 4.85 lakhs, and the loss per equity share was Rs. 0.16.
Aditya Birla Fashion and Retail Ltd
Aditya Birla Fashion and Retail Ltd has announced the Integrated Annual Report for the Financial Year 2025-26 and the Notice of the 19th Annual General Meeting. The report and notice are available on the company's website and on the websites of BSE and NSE.
Sportking India Limited
Sportking India Limited has informed the Exchange regarding Change in Director(s) of the company. The Board of Directors has approved the change in designation of Mrs. Anjali Avasthi from Non-Executive Director to Whole-time Director, designated as Executive Director, for a period of three (3) years with effect from August 1, 2026. The company has also approved the unaudited financial results for the quarter ended 30th June, 2026, along with a limited review report.
Vishnu Chemicals Ltd
Vishnu Chemicals Ltd has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The company reported a net profit of ₹3,964.22 lakhs, a 23.5% increase from the previous quarter's net profit of ₹3,222.45 lakhs. The company's revenue from operations was ₹43,340.60 lakhs, a 1.2% increase from the previous quarter's revenue of ₹42,691.55 lakhs.
Amj Land Holdings Limited
Amj Land Holdings Limited has submitted its financial results for the quarter ended June 30, 2026, with a total income of Rs. 676.68 lakhs and a profit before tax of Rs. 536.04 lakhs.
Groarc Industries India Ltd
Groarc Industries India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 to consider and approve the un-audited standalone financial results for the quarter ended June 30, 2026 and limited review report thereon.
Aarti Drugs Ltd
Aarti Drugs Ltd has announced its Q1FY27 investor presentation, highlighting a strong operational and financial performance with a 19% YoY revenue growth, 30% YoY EBITDA growth, and 35% YoY PBT growth. The company's API and Speciality Chemicals portfolio saw improved realizations and volume growth, contributing to the robust quarter.
Mangalam Global Enterprise Ltd
Mangalam Global Enterprise Ltd has announced its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company reported a net profit of ₹752.93 crore, a 23% increase from the previous quarter's net profit of ₹616.08 crore. The results were reviewed and recommended by the Audit Committee and approved by the Board of Directors on August 1, 2026.
Telogica Ltd
Telogica Ltd has published a notice of AGM and unaudited financial results for Hypersoft Technologies Ltd, a subsidiary, for the quarter ended June 30, 2026.
Aarti Drugs Limited
Aarti Drugs Limited has released its Q1 FY27 investor presentation, highlighting a strong operational and financial performance driven by volume growth, improved realizations, and disciplined execution. The company reported a 19% YoY increase in net revenue from operations, with EBITDA and PBT margins expanding by 120bps and 120bps, respectively. The company's management commentary attributed the performance to a recovery in the pricing environment and operational efficiencies.
Niwas Spinning Mills Ltd
Niwas Spinning Mills Ltd has scheduled a board meeting on 14/08/2026 to consider and approve un-audited financial results for the quarter ended 30th June 2026.
SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd has announced its audited standalone and consolidated financial results for the first quarter ended June 30, 2026, which are available on its website and in newspapers.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has published its unaudited standalone financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 725 million, compared to a net profit of Rs. 5,872 million in the previous quarter.
Aarti Drugs Ltd
Aarti Drugs Ltd reported its Q1FY27 business and financial performance, with revenue growing 19% YoY to Rs. 703.6 crore, EBITDA increasing 30% YoY to Rs. 96.9 crore, and EBITDA margin expanding 120 bps to 13.8%. The company's CFO & COO, Mr. Adhish Patil, attributed the strong performance to a mix of volume growth and improved realizations across its API & Speciality Chemicals portfolio, as well as disciplined execution.
Sportking India Limited
Sportking India Limited has announced its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report. The company has also approved the change in designation of Mrs. Anjali Avasthi from Non-Executive Director to Whole-time Director, and has scheduled its 37th Annual General Meeting for September 12, 2026.
Siyaram Silk Mills Ltd-$
Siyaram Silk Mills Ltd has published unaudited financial results for the quarter ended 30th June 2026 in newspapers The Economic Times and Maharashtra Times.
SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd has released its Q1FY27 investor presentation, highlighting a 6% YoY revenue growth, sustained EBITDA margin of ~20%, and an 8% YoY PAT growth. The company has completed 4 DMF/CEP filings and is on track to meet its FY27 target of 10 filings. A ₹280 crore capex programme is progressing as planned, and the board has approved an infusion of up to ₹50 crore into its subsidiary SMS Peptides Private Limited.
Vasundhara Rasayans Ltd
Vasundhara Rasayans Ltd has announced its 39th Annual Report and Notice of AGM for the financial year ended 31st March, 2026, along with the proposed resolutions to be discussed at the meeting.